STERIS plc (NYSE:STE) Shares Sold by Courier Capital LLC

Courier Capital LLC trimmed its stake in shares of STERIS plc (NYSE:STE) by 25.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,329 shares of the medical equipment provider’s stock after selling 445 shares during the quarter. Courier Capital LLC’s holdings in STERIS were worth $292,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Global Retirement Partners LLC lifted its holdings in STERIS by 9.4% during the first quarter. Global Retirement Partners LLC now owns 570 shares of the medical equipment provider’s stock valued at $128,000 after purchasing an additional 49 shares in the last quarter. First Hawaiian Bank lifted its holdings in STERIS by 0.4% during the first quarter. First Hawaiian Bank now owns 13,857 shares of the medical equipment provider’s stock valued at $3,115,000 after purchasing an additional 50 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund lifted its holdings in STERIS by 1.5% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 3,520 shares of the medical equipment provider’s stock valued at $774,000 after purchasing an additional 53 shares in the last quarter. J.Safra Asset Management Corp lifted its holdings in STERIS by 77.9% during the first quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Finally, Mather Group LLC. lifted its holdings in STERIS by 7.6% during the second quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider’s stock valued at $172,000 after purchasing an additional 54 shares in the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

STE has been the topic of several research reports. JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Wednesday, August 7th. StockNews.com raised shares of STERIS from a “hold” rating to a “buy” rating in a research note on Tuesday, August 13th. Piper Sandler reissued a “neutral” rating and issued a $225.00 price target (up from $220.00) on shares of STERIS in a research note on Friday, May 10th. Stephens reissued an “overweight” rating and issued a $260.00 price target on shares of STERIS in a research note on Wednesday, August 7th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Thursday, August 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $243.60.

STERIS Trading Down 0.0 %

STE stock traded down $0.11 during trading on Thursday, reaching $234.27. 142,199 shares of the stock were exchanged, compared to its average volume of 481,523. The company has a current ratio of 2.33, a quick ratio of 1.49 and a debt-to-equity ratio of 0.35. The business has a 50 day moving average price of $226.32 and a 200-day moving average price of $223.85. STERIS plc has a 1 year low of $195.47 and a 1 year high of $243.37. The firm has a market capitalization of $23.10 billion, a price-to-earnings ratio of 61.33 and a beta of 0.83.

STERIS (NYSE:STE) last issued its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $1.98 by $0.16. STERIS had a net margin of 7.36% and a return on equity of 13.85%. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm earned $2.00 earnings per share. STERIS’s quarterly revenue was down .4% compared to the same quarter last year. On average, research analysts predict that STERIS plc will post 9.17 earnings per share for the current year.

STERIS Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Thursday, September 5th will be issued a $0.57 dividend. The ex-dividend date of this dividend is Thursday, September 5th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.97%. This is a boost from STERIS’s previous quarterly dividend of $0.52. STERIS’s payout ratio is 54.45%.

Insiders Place Their Bets

In other news, Director Christopher S. Holland sold 473 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $239.68, for a total transaction of $113,368.64. Following the completion of the sale, the director now owns 582 shares in the company, valued at approximately $139,493.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is currently owned by company insiders.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.